购物车
- 全部删除
- 您的购物车当前为空
Ivarmacitinib (SHR0302) sulfate 是一种具有口服活性的有效JAK抑制剂,尤其针对JAK1的选择性是JAK2的10倍以上,是JAK3的77倍,是Tyk2的420倍。Ivarmacitinib 抑制JAK1-STAT3磷酸化并诱导肝星状细胞凋亡 (apoptosis),具有抗增殖和抗炎作用。
Ivarmacitinib (SHR0302) sulfate 是一种具有口服活性的有效JAK抑制剂,尤其针对JAK1的选择性是JAK2的10倍以上,是JAK3的77倍,是Tyk2的420倍。Ivarmacitinib 抑制JAK1-STAT3磷酸化并诱导肝星状细胞凋亡 (apoptosis),具有抗增殖和抗炎作用。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 询价 | 10-14周 | |
50 mg | 询价 | 10-14周 |
产品描述 | Ivarmacitinib (SHR0302) sulfate, a potent and orally active inhibitor of all JAK family members, exhibits particular selectivity towards JAK1. Its selectivity is >10-fold greater for JAK1 compared to JAK2, 77-fold more than JAK3, and 420-fold more than Tyk2. Ivarmacitinib effectively inhibits JAK1-STAT3 phosphorylation, thereby inducing apoptosis in hepatic stellate cells. Additionally, it demonstrates notable anti-proliferative and anti-inflammatory properties [1] [2]. |
别名 | SHR0302 sulfate |
分子量 | 512.56 |
分子式 | C18H24N8O6S2 |
CAS No. | 1639419-51-4 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.